Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial
Titel:
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial
Auteur:
De Placido, Sabino Gallo, Ciro De Laurentiis, Michelino Bisagni, Giancarlo Arpino, Grazia Sarobba, Maria Giuseppa Riccardi, Ferdinando Russo, Antonio Del Mastro, Lucia Cogoni, Alessio Aligi Cognetti, Francesco Gori, Stefania Foglietta, Jennifer Frassoldati, Antonio Amoroso, Domenico Laudadio, Lucio Moscetti, Luca Montemurro, Filippo Verusio, Claudio Bernardo, Antonio Lorusso, Vito Gravina, Adriano Moretti, Gabriella Lauria, Rossella Lai, Antonella Mocerino, Carmela Rizzo, Sergio Nuzzo, Francesco Carlini, Paolo Perrone, Francesco